Biotech Inscript

About Publications Sign in Subscribe

Former Google AI Expert's Biotech Start-Up Raises $100 Million for AI-Driven Drug Innovation

Former Google AI Expert's Biotech Start-Up Raises $100 Million for AI-Driven Drug Innovation

Inceptive, founded by a former Google AI expert, secures $100M in funding from investors like Nvidia and Andreessen Horowitz to advance AI-driven biotech initiatives

Top Stories

Roche to Acquire Carmot Therapeutics in a $3.1 Billion Deal

Roche to acquire Carmot Therapeutics for $3.1B, gaining access to innovative obesity and diabetes treatments. The deal includes clinical-stage assets with potential for standalone and combination therapies. Expected to close in Q1 2024, pending regulatory approval.

Samsung Biologics and VC Firm Kurma Partners Announce Biologics Manufacturing Partnership for Kurma's Portfolio Companies

Samsung Biologics & Kurma Partners team up for biologics development & manufacturing, empowering startups in Kurma's portfolio with tailored CMC services & global expertise. A strategic partnership driving biopharmaceutical innovation.

Edesa Biotech Secures C$23 Million Canadian Govt. Funding to Accelerate Breakthrough Immune Treatment

Edesa Biotech secures C$23 million in government funding for Phase 3 clinical study of EB05, a pioneering immune therapy, as announced in their press release. The funding reinforces their commitment to advancing healthcare innovation.

Latest

OncoNPC: Revolutionary Tool To Help Doctors Identify and Treat Cancers of Unknown Origin

August 7, 2023: Researchers at the Massachusetts Institute of Technology (MIT) and the Dana-Farber Cancer Institute have developed a groundbreaking approach utilising machine learning to address the challenge of identifying the origins of enigmatic cancers. Employing a computational model, the scientists have devised a method to analyse the genetic sequence

Scientists Develop New Bioink for 3D Bioprinting of Tumour Models

August 7, 2023: Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed a new bioink that can be used to create more accurate 3D tumour models. The bioink, which is made with a combination of gelatin methacryloyl (GelMA) and Laponite, has improved bonding and cross-linking capabilities, which allows

Breakthrough In Gene Editing: Scientists Uncover New Role For CRISPR-Cas System

02 Aug, 2023: A research team led by Professor Dr. Alexander Probst has made a groundbreaking discovery that archaea, which are microorganisms bearing resemblance to bacteria, employ the CRISPR-Cas system as a defence mechanism against parasites. The researchers arrived at this conclusion by conducting an in-depth genomic analysis, encompassing more

Unraveling the Wonders of Genomics and Proteomics at the London Biotechnology Show.

Ever wondered what makes you different from others? Cherished or disliked, why do you have specific features or traits that set you apart? The answers lie in the fascinating fields of genomics and proteomics, which are like the keys to unlock the secrets of your unique existence. In the rapidly

Exploring Europe’s Disruptive Biotechnology Landscape

In the dynamic realm of biotechnology, Europe stands as a vibrant hub of innovation, harbouring a diverse array of pioneering companies that have propelled the industry to unprecedented heights. From groundbreaking advancements in genomics and personalised medicine to cutting-edge developments in agricultural biotechnology, European biotech firms have continually pushed the

Embracing Biopharming at the London Biotechnology Show: A Revolutionary Path to Sustainable Medicine

Nature has been a perennial source of remedy and cure for humanity. We have Aspirin yielding willow trees, and Artemisinin used as treatment for malaria. Adding to these magical powers of nature, science has manipulated it more to produce high-valued pharmaceuticals. This method to transform plants, animals and microbes into

Scientists Unveil Groundbreaking Self-Sensing Electric Artificial Muscles

23 July 2023: Researchers from Queen Mary University of London have achieved a momentous feat in the realm of bionics by engineering a novel self-sensing, variable-stiffness artificial muscle that closely mimics the characteristics of natural muscle. This groundbreaking technology has far-reaching implications in the field of soft robotics and medical